Back to MW MARSHALL WACE, LLP
TRVIShowing 8 of 12 quarters
Position history for MWMARSHALL WACE, LLP's holdings in Trevi Therapeutics, Inc.
MARSHALL WACE, LLP holds 2.7M shares of TRVI (Trevi Therapeutics, Inc.), worth $49.9M as of 2026-Q2. The position was decreased (-32.6% shares). TRVI represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$49.9M
Current Shares
2.7M
Total Value Change
+$49.6M
Total Shares Change
+2.6M
Quarter-by-Quarter History
Other major holders of TRVI: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP